We are live on ! Find out more
TMCI icon

Treace Medical Concepts
TMCI

137 hedge funds and large institutions have $996M invested in Treace Medical Concepts in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 64 increasing their positions, 35 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more call options, than puts

Call options by funds: $3.03M | Put options by funds: $519K

117% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 12

83% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 35

11% more funds holding

Funds holding: 123 → 137 (+14)

11% more capital invested

Capital invested by funds: $895M → $996M (+$101M)

5.39% more ownership

Funds ownership: 58.1% → 63.49% (+5.4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
137
Holders Change
+14
Holders Change %
+11.38%
% of All Funds
2.15%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
26
Increased
64
Reduced
35
Closed
12
Calls
$3.03M
Puts
$519K
Net Calls
+$2.52M
Net Calls Change
-$10.7M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$27.5M
2
DCM
Driehaus Capital Management
Illinois
+$18.7M
3
BlackRock
BlackRock
New York
+$13.6M
4
Deutsche Bank
Deutsche Bank
Germany
+$8.95M
5
State Street
State Street
Massachusetts
+$7.31M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$12.9M
2
SPPAM
Summit Partners Public Asset Management
Massachusetts
-$9.38M
3
Marshall Wace
Marshall Wace
United Kingdom
-$7.13M
4
PA
Perceptive Advisors
New York
-$5.81M
5
Millennium Management
Millennium Management
New York
-$4.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$9.7M +$2.53M +97,910 +35%
Deutsche Bank
27
Deutsche Bank
Germany
$9.5M +$8.95M +346,949 +1,423%
NHAS
28
Novo Holdings A/S
Denmark
$9.21M -$4.65M -180,000 -33%
IECM
29
Intrinsic Edge Capital Management
Illinois
$9.07M +$1.57M +60,812 +21%
Charles Schwab
30
Charles Schwab
California
$7.27M +$545K +21,119 +8%
Russell Investments Group
31
Russell Investments Group
United Kingdom
$7.24M -$1.24M -48,038 -15%
PCM
32
Peregrine Capital Management
Minnesota
$7.16M -$2.25K -87 -0%
PI
33
Putnam Investments
Massachusetts
$6.89M +$891K +34,523 +15%
OAM
34
Oberweis Asset Management
Illinois
$6.43M +$2.51M +97,200 +63%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$6.16M +$2.63M +101,899 +73%
SAM
36
Silvercrest Asset Management
New York
$5.72M +$5.78M +223,757 New
SEI Investments
37
SEI Investments
Pennsylvania
$5.48M +$778K +30,124 +16%
LCG
38
Lisanti Capital Growth
New York
$4.59M +$4.64M +179,605 New
Ameriprise
39
Ameriprise
Minnesota
$4.55M +$1.01M +39,154 +28%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$4.18M +$1.02M +39,645 +32%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$4.17M +$1.49M +57,755 +55%
Calamos Advisors
42
Calamos Advisors
Illinois
$3.94M -$660K -25,568 -14%
WP
43
Woodline Partners
California
$3.5M +$3.54M +137,011 New
CM
44
Castleark Management
Illinois
$3.17M -$141K -5,470 -4%
Millennium Management
45
Millennium Management
New York
$3.13M -$4.92M -190,578 -61%
IGAM
46
iA Global Asset Management
Quebec, Canada
$3.09M +$3.12M +120,920 New
FG
47
Formula Growth
Quebec, Canada
$3.01M -$185K -7,150 -6%
Goldman Sachs
48
Goldman Sachs
New York
$2.99M -$180K -6,963 -6%
UOC
49
UBS O'Connor
Illinois
$2.88M -$854K -33,106 -23%
Two Sigma Investments
50
Two Sigma Investments
New York
$2.82M +$19.7K +763 +0.7%
1
2
3 4 5

TMCI Hedge Fund Activity: Q2 2023 in Review

137 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q2 2023, worth a combined $996M — up 11% from $895M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new TMCI positions and 12 closed out — a net gain of 14 holders — while 64 added to existing stakes and 35 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $27.5M. The largest seller was Citadel Advisors, cutting an estimated $12.9M.

  • 137 institutional investors held Treace Medical Concepts (TMCI) as of Q2 2023, up from 123 in Q1 2023.
  • Funds reported $996M of Treace Medical Concepts stock for Q2 2023, up 11% quarter-over-quarter.
  • 26 funds opened new Treace Medical Concepts positions in Q2 2023 and 12 closed out, a net change of +14 holders.
  • The largest Treace Medical Concepts buyer in Q2 2023 was Point72 Asset Management, an estimated $27.5M added.
  • The largest Treace Medical Concepts seller in Q2 2023 was Citadel Advisors, an estimated $12.9M sold.

Based on aggregated 13F filings for Q2 2023.